Equilibar has released a single use pressure control valve for use in the biopharma industry among others. The valve was first introduced on April 17, 2018 during the InterPhex BioPharma trade show in New York City.
This specialty instrument was developed in response to the biopharma industrys rapidly expanding requirements for low cost components that can be sterilized through radiation and disposed of immediately after use. It is also appropriate for other service conditions that require single use components.
The valves patent pending design offers USP Class VI polymers that can be sterilized as an assembly. Only the wetted components and diaphragm are disposable and are inserted into a permanent stainless steel support housing for quick and easy assembly. The Single Use Equilibar features the same dome-loaded multiple orifice technology as all Equilibar patented products, delivering instantaneous control, frictionless operation, superior precision, and exceptionally wide flow rate ranges. Its strengths are particularly well suited to control the transmembrane pressure in tangential flow filtration control applications.
Were excited about the potential for the Single Use Equilibar to bring our revolutionary technology to many more markets, said Design Engineer Ryan Heffner, who specializes in biopharma applications as well as other complex pressure control applications. Equilibar® back pressure regulators and vacuum control valves operate in a completely different way than traditional pressure control products, and were excited to bring our technology into a new sphere.
Image courtesy of Equilibar